Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting in breast cancer NST trials. The COS was developed in three phases according to COS-STAD guidance, with the generation of a list of relevant outcome domains, prioritisation of outcomes through two rounds of an international online multi-stakeholder Delphi survey and a consensus meeting. 159 unique locoregional outcomes were classified into 101 outcome domains for inclusion in the Delphi survey, which was completed by 470 international professionals. The final 15-item COS, which included the pre-NST surgical plan, details of surgery performed following completion of treatment and details of radiation therapy, was agreed at an in-person consensus meeting. Widespread COS implementation will improve the quality and value of future NST trials.

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials / Potter S.; Avery K.; Ahmed R.; de Boniface J.; Chatterjee S.; Dodwell D.; Dubsky P.; Federmann J.; Finestone S.; Gnant M.; Hlauschek D.; Iwata H.; Jiang M.Y.; Kaidar-Person O.; Lee H.-B.; MacKenzie M.; Meyn A.; Poortmans P.; Poulakaki F.; Richardson A.L.; Sepulveda K.A.; Spillane A.J.; Thompson A.M.; Werutsky G.; Wittmann P.; Wright J.L.; Zdenkowski N.; Cowan K.; McIntosh S.A.; Zope A.; Zivkovic M.; Zeko A.; Cobos G.Z.; Zatecky J.; Youn H.J.; Yiallourou A.; Yeh J.; Kumar S.; Wyld L.; Wong S.; Wiebe E.; Warnberg F.; Wapnir I.; Walker M.; Wadasadawala T.; Voutsadakis I.; Vohra L.; Vidal-Sicart S.; Venkitaraman R.; Velu U.; Vazquez-Barreiro B.; Vandermeulen A.; Van Maaren M.C.; Duijnhoven F.V.; Hage J.V.D.; Berkmortel F.V.D.; Valachis A.; Vaidya J.; Ueno T.; Tvedskov T.; Tsoutsou P.; Tsiatas M.; Thorat M.; Thomson J.; Thaweerat W.; Tezcanli E.; Liutti V.T.; Taylor D.; Tavoletta M.S.; Tandon M.; Swinden M.; Susini T.; Suga Y.; Stuart K.; Stranzl H.; Spanheimer P.; De Celis E.S.P.; Snook K.; Smith F.; Sirohi B.; Simcock R.; Silva A.; Sidiropoulou Z.; Sibbering M.; Shoshkova M.; Shetty P.S.; Shenoy S.; Sharma S.; Sharawy I.; Shanthilal M.; Setakornnukul J.; Serra M.; Scardina L.; Savva C.; Sanchez-Mendez J.I.; Salinas J.E.; Saha S.; Sackey H.; Ryu J.M.; Ruyssers N.; Russell N.; Rubio I.T.; Rovera F.; Rosset L.; Roshanlall C.; Rojas B.; Rocco N.; Roberts N.; Riis M.; Retamales J.; Reinert T.; Redfern A.; Rebaza L.; Read R.; Razis E.; Ratosa I.; Rao S.; Ramiah D.; Rahim I.U.; Radhakrishnan V.; Putora P.M.; Puchinskaya M.; Provenzano E.; Moura J.F.P.; Portik D.; Porpiglia M.; Poppe M.; Popescu R.; Pogoda K.; Pinero-Madrona A.; Segura C.P.; Peretz-Yablonski T.; Pellegrini A.; Pasquier D.; Pascual J.; Papadopoulos L.; Ferrando A.O.; Bagge R.O.; Oikonomou I.; O'Reilly S.; O'Neill C.; Nikopoulou A.; Nikolic D.; Nguyen T.; Narui K.; Sanchez M.A.N.; Namiq K.; Murawa D.; Munzone E.; Miguelanez T.M.; Morgan J.; Montero A.; Misra S.; Minisini A.M.; Meterissian S.; Meretoja T.; Meduri B.; Meattini I.; Maulik S.; Mau C.I.; Masuda N.; Masiello V.; Masannat Y.; Martos T.; Martin-Quesada A.I.; Marti C.; Martel K.; Marta G.; Margenthaler J.; Marcou Y.; Maraldo M.; Mantilla W.; Mansell J.; Mando P.; Makris G.M.; Maduro J.; Madeira P.; Macpherson I.; Macinnes E.; Machiels M.; Luzi M.; Luftner D.; Ludwig M.; Valenti E.L.; Liang R.; Lee J.; Leal S.; Laws S.; Kunkler I.; Krug D.; Kretsi A.; Kontos M.; Konstantis A.; Konsoulova A.; Ko H.S.; Klein E.; Kirwan C.; Kipps E.; Kihn-Alarcon A.; Khan M.M.; Karamanliev M.; Karakatsanis A.; Cakmak G.K.; Kanyadhara L.K.; Kang T.; Polat A.K.; Kadayaprath G.; Chanthar V.; Jung J.-J.; Jung K.; Johnson N.; Johnson C.; Jerzak K.; Jerusalem G.; James M.; Jagsi R.; Irwin G.; Illarramendi J.J.; Ikram R.; Huscher A.; Huda F.; Hubbard T.; Hsu C.; Hijal T.; Heidinger M.; Hegarty G.; Harris G.; Hariharan N.; Hajjaji N.; Hadar T.; Gunay S.; Grossmann C.; Grobmyer S.; Gossling G.; Gomez H.L.; Gil-Gil M.; Ghilli M.; Generali D.; Gasparri M.L.; Garach N.; Fuentes H.; Franceschini G.; Fougo J.; Fiorica F.; Ferreiro J.; Fernandez-Morales L.; Fernandez I.; Fancellu A.; Fahmy W.; Fabiano V.Y.; Estevez-Diz M.D.P.; Espinosa-Bravo M.; Esakia T.; Erel S.; Eraso A.; Elsberger B.; Elfgen C.; Elder E.; Eiriz I.; Edge J.; Ebner F.; Duane F.; Dragoumis D.; Douvetzemis S.; Dougoud-Chauvin V.; Dogan L.; Dimitrov D.; Diaz-Gavela A.A.; Micco R.D.; Deschuymer S.; Delaney G.P.; Berron S.D.B.; Pinta C.D.L.; Caluwe A.D.; Davies M.; Daskalova I.; Daiuto M.; Cutress R.; Cruz J.; Cretella E.; Crawford K.; Cortes P.; Corsi F.; Corradini S.; Copson E.; Coopey S.; Constantinidou A.; Conde-Herrero V.; Collins J.; Claros J.; Choraria A.; Chiu M.K.L.; Chen S.; Chan N.; Castillo C.; Carmichael A.; Peterko A.C.; Omer-Canturk A.; Cano-Jimenez A.; Campbell B.; Cain H.; Burnette B.; Bulbuloglu G.C.; Bueno C.; Bucci E.O.; Brown-Glaberman U.; Branson T.; Borg E.; Bonetti A.; Bonci E.-A.; Boersma L.; Bjelic-Radisic V.; Bhattacharya I.; Beurer B.; Berpan A.; Bernstein-Molho R.; Berardi R.; Becherini C.; Barry P.; Barrette V.; Banys-Paluchowski M.; Bando H.; Backianathan S.; Aznar M.; Asif F.; Aristei C.; Arikan A.E.; Aragon S.; Ancao M.B.; Amreen S.; Amirov N.; Garcia R.; Aligizakis E.; Algara M.; Albacar C.; Agarwal G.; Aebi S.; Haris P.A.; Abdelwahab K.; Abdah-Bortnyak R.; Abbott N.. - In: NPJ BREAST CANCER. - ISSN 2374-4677. - ELETTRONICO. - 11:(2025), pp. 116.0-116.0. [10.1038/s41523-025-00824-w]

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

Susini T.;Meattini I.;Becherini C.;
2025

Abstract

Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting in breast cancer NST trials. The COS was developed in three phases according to COS-STAD guidance, with the generation of a list of relevant outcome domains, prioritisation of outcomes through two rounds of an international online multi-stakeholder Delphi survey and a consensus meeting. 159 unique locoregional outcomes were classified into 101 outcome domains for inclusion in the Delphi survey, which was completed by 470 international professionals. The final 15-item COS, which included the pre-NST surgical plan, details of surgery performed following completion of treatment and details of radiation therapy, was agreed at an in-person consensus meeting. Widespread COS implementation will improve the quality and value of future NST trials.
2025
11
0
0
Goal 3: Good health and well-being
Potter S.; Avery K.; Ahmed R.; de Boniface J.; Chatterjee S.; Dodwell D.; Dubsky P.; Federmann J.; Finestone S.; Gnant M.; Hlauschek D.; Iwata H.; Jia...espandi
File in questo prodotto:
File Dimensione Formato  
41523_2025_Article_824.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 718.59 kB
Formato Adobe PDF
718.59 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1446390
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact